• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国女性导管原位癌发病率 25 年趋势

Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women.

机构信息

Department of Surgery, Massachusetts General Hospital, Boston, MA.

Department of Surgery, Massachusetts General Hospital, Boston, MA.

出版信息

J Am Coll Surg. 2019 Jun;228(6):932-939. doi: 10.1016/j.jamcollsurg.2019.01.018. Epub 2019 Feb 15.

DOI:10.1016/j.jamcollsurg.2019.01.018
PMID:30772444
Abstract

BACKGROUND

The rising incidence of ductal carcinoma in situ (DCIS) since the widespread enactment of mammography screening has been well documented. Patterns in DCIS incidence among women of various ages and across different racial and ethnic groups have not been well described.

STUDY DESIGN

The Surveillance, Epidemiology, and End Results public-use data set was queried for all women aged 40 years and older diagnosed with DCIS between 1990 and 2014. Annual age-adjusted incidence rates were compared among white, black, Hispanic, and Asian-Pacific Islander women. Additionally, using mammography screening data obtained from the CDC, patterns in mammography screening over time and as they relate to DCIS incidence rates by race and ethnicity were evaluated.

RESULTS

We identified 200,400 women aged 40 years or older with DCIS. Between 1998 and 2014, a period that saw flux in national breast screening guidelines, DCIS incidence rates increased in blacks, Hispanics, and Asian-Pacific Islanders, but remained relatively unchanged in whites (increase in number of DCIS diagnoses per 100,000 individuals in the population per year among blacks +0.66/p < 0.01, Hispanics +3.0/p < 0.01, Asian-Pacific Islanders +0.53/p < 0.01, and whites +0.07/p = 0.21). After accounting for age, year of diagnosis, and mammography screening rates, DCIS incidence was found to be similar between white and black women (0.8 fewer diagnoses per 100,000 individuals compared with whites; p = 0.36) but lower for Hispanic women (9.7 fewer diagnoses per 100,000 individuals compared with whites; p < 0.01).

CONCLUSIONS

The DCIS incidence rates are influenced substantially by breast cancer mammography screening patterns. However, differences exist by race and ethnicity and are not fully explained by screening mammography trends alone. Consideration should be given to including race and ethnicity in determining optimal breast screening guidelines.

摘要

背景

自乳房 X 光筛查广泛实施以来,导管原位癌(DCIS)的发病率不断上升,这一点已有充分记录。不同年龄段和不同种族和族裔群体中 DCIS 发病率的模式尚未得到很好的描述。

研究设计

使用监测、流行病学和最终结果公共数据集,查询了 1990 年至 2014 年间诊断为 DCIS 的所有 40 岁及以上的女性。比较了白种人、黑种人、西班牙裔和亚太岛民女性的年年龄调整发病率。此外,还利用从疾病控制与预防中心获得的乳房 X 光筛查数据,评估了随着时间的推移以及与种族和族裔的 DCIS 发病率相关的乳房 X 光筛查模式。

结果

我们确定了 200,400 名 40 岁或以上患有 DCIS 的女性。在 1998 年至 2014 年期间,国家乳房筛查指南不断变化,黑人、西班牙裔和亚太岛民的 DCIS 发病率上升,但白人的发病率相对不变(每 10 万人群中每年 DCIS 诊断人数的增加黑人+0.66/p<0.01,西班牙裔+3.0/p<0.01,亚太岛民+0.53/p<0.01,白人+0.07/p=0.21)。在考虑年龄、诊断年份和乳房 X 光筛查率后,发现白人和黑人妇女的 DCIS 发病率相似(与白人相比,每 10 万人中少 0.8 例诊断;p=0.36),但西班牙裔妇女的发病率较低(与白人相比,每 10 万人中少 9.7 例诊断;p<0.01)。

结论

DCIS 发病率受乳腺癌乳房 X 光筛查模式的显著影响。然而,不同种族和族裔之间存在差异,仅凭乳房 X 光筛查趋势无法完全解释。在确定最佳乳房筛查指南时,应考虑将种族和族裔因素纳入考虑。

相似文献

1
Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women.美国女性导管原位癌发病率 25 年趋势
J Am Coll Surg. 2019 Jun;228(6):932-939. doi: 10.1016/j.jamcollsurg.2019.01.018. Epub 2019 Feb 15.
2
Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women.加利福尼亚州女性乳腺导管原位癌发病率及治疗的近期趋势与种族/民族差异
Cancer. 2003 Feb 15;97(4):1099-106. doi: 10.1002/cncr.11104.
3
Incidence of and treatment for ductal carcinoma in situ of the breast.乳腺导管原位癌的发病率及治疗方法
JAMA. 1996 Mar 27;275(12):913-8.
4
Incidence of Ductal Carcinoma in the United States, 2000-2014.美国 2000-2014 年导管癌发病情况。
Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1316-1323. doi: 10.1158/1055-9965.EPI-18-1262. Epub 2019 Jun 11.
5
Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.美国亚裔/太平洋岛民、西班牙裔和非裔美国女性近期的乳腺癌发病趋势:按肿瘤亚型划分的变化
Breast Cancer Res. 2007;9(6):R90. doi: 10.1186/bcr1839.
6
Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ?数字乳腺 X 线摄影筛查:年龄是否影响低级别、中级别和高级别导管原位癌的检出率?
Radiology. 2016 Mar;278(3):707-13. doi: 10.1148/radiol.2015150322. Epub 2015 Oct 27.
7
Trends in incidence and treatment for ductal carcinoma in situ in Hispanic, American Indian, and non-Hispanic white women in New Mexico, 1973-1994.1973 - 1994年新墨西哥州西班牙裔、美国印第安人和非西班牙裔白人女性原位导管癌的发病率及治疗趋势
Cancer. 1999 Mar 1;85(5):1084-90. doi: 10.1002/(sici)1097-0142(19990301)85:5<1084::aid-cncr11>3.0.co;2-5.
8
A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase.一项对 2000 年至 2009 年美国乳腺癌发病率的趋势分析显示,发病率最近有所上升。
Breast Cancer Res Treat. 2013 Apr;138(2):633-41. doi: 10.1007/s10549-013-2434-0. Epub 2013 Feb 28.
9
Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.乳腺导管原位癌(DCIS)与乳腺钼靶检查相关的增加:一个困境。
J Natl Cancer Inst Monogr. 1997(22):151-6. doi: 10.1093/jncimono/1997.22.151.
10
Trends in breast cancer by race and ethnicity: update 2006.不同种族和族裔的乳腺癌发病趋势:2006年更新
CA Cancer J Clin. 2006 May-Jun;56(3):168-83. doi: 10.3322/canjclin.56.3.168.

引用本文的文献

1
High-resolution microCT to assess breast microcalcification morphometry by histologic lesion subtype and radiologic classification.通过组织学病变亚型和放射学分类,利用高分辨率显微CT评估乳腺微钙化形态学。
Breast Cancer Res Treat. 2025 Nov;214(1):49-58. doi: 10.1007/s10549-025-07792-6. Epub 2025 Aug 17.
2
Incidence trends of ductal carcinoma in situ in New Zealand women between 1999 and 2022.1999年至2022年间新西兰女性原位导管癌的发病趋势。
Breast Cancer Res Treat. 2025 Apr;210(2):439-449. doi: 10.1007/s10549-024-07582-6. Epub 2025 Jan 25.
3
The Role of Residential Segregation in Treatment and Outcomes of Ductal Carcinoma In Situ of the Breast.
居住隔离在乳腺导管原位癌治疗及预后中的作用
Cancer Epidemiol Biomarkers Prev. 2024 Dec 2;33(12):1633-1639. doi: 10.1158/1055-9965.EPI-24-0488.
4
Cost containment analysis of superparamagnetic iron oxide (SPIO) injection in patients with ductal carcinoma in situ.乳腺导管原位癌患者注射超顺磁性氧化铁(SPIO)的成本控制分析。
Breast Cancer Res Treat. 2024 Dec;208(3):565-568. doi: 10.1007/s10549-024-07451-2. Epub 2024 Aug 1.
5
Radiology for Ductal Carcinoma In Situ of the Breast: Updates on Invasive Cancer Progression and Active Monitoring.乳腺导管原位癌的放射学:浸润性癌进展和主动监测的更新。
Korean J Radiol. 2024 Aug;25(8):698-705. doi: 10.3348/kjr.2024.0117. Epub 2024 Jul 4.
6
Age and race/ethnicity differences in decisional conflict in women diagnosed with ductal carcinoma in situ.原位导管癌女性患者决策冲突中的年龄及种族/民族差异。
BMC Womens Health. 2024 Feb 4;24(1):89. doi: 10.1186/s12905-024-02935-1.
7
Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era.经皮活检时代的良性乳腺疾病与乳腺癌风险。
JAMA Surg. 2024 Feb 1;159(2):193-201. doi: 10.1001/jamasurg.2023.6382.
8
An insight into the invasion of breast ductal carcinoma based on clinical, pathological and hematological data.基于临床、病理和血液学数据的乳腺导管癌浸润的深入了解。
PeerJ. 2022 Aug 31;10:e13966. doi: 10.7717/peerj.13966. eCollection 2022.
9
Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study.基底样乳腺癌原位至浸润性进展的分子特征:一项整合的小鼠模型和人导管原位癌研究
NPJ Breast Cancer. 2022 Jul 18;8(1):83. doi: 10.1038/s41523-022-00450-w.
10
Is conservative management of ductal carcinoma in situ risky?导管原位癌的保守治疗有风险吗?
NPJ Breast Cancer. 2022 Apr 28;8(1):55. doi: 10.1038/s41523-022-00420-2.